Rex Hematology Oncology Associates-Blue Ridge — Raleigh, North Carolina

Rex Hematology Oncology Associates-Blue Ridge is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Rex Hematology Oncology Associates-Blue Ridge has participated in 13 clinical trials with 9 currently active.

Therapeutic areas: Breast Cancer, Breast Adenocarcinoma, Estrogen Receptor Negative.

Sponsors: SWOG Cancer Research Network, NRG Oncology, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Raleigh

Browse all research sites in North Carolina · View every site in Raleigh

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rex Hematology Oncology Associates-Blue Ridge?

Rex Hematology Oncology Associates-Blue Ridge has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rex Hematology Oncology Associates-Blue Ridge conducted?

Rex Hematology Oncology Associates-Blue Ridge has 13 clinical trials on record, with 9 currently active. Their work covers Breast Cancer, Breast Adenocarcinoma, Estrogen Receptor Negative.

Is Rex Hematology Oncology Associates-Blue Ridge accredited by Crixeo Clinical Trials?

Rex Hematology Oncology Associates-Blue Ridge has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rex Hematology Oncology Associates-Blue Ridge?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.